Document:

EX-10.2

 Exhibit 10.2 

EXECUTION VERSION 
 Amendment
No. 6 
 AMENDMENT NO. 6, dated as of February 25, 2015 (this “Amendment”), by and among PAR
PHARMACEUTICAL COMPANIES, INC., a Delaware corporation (the “Parent Borrower”), PAR PHARMACEUTICAL, INC., a Delaware corporation (the “Co-Borrower” and, together with the Parent Borrower, the
“Borrowers” and each a “Borrower”), SKY GROWTH INTERMEDIATE HOLDINGS II CORPORATION, a Delaware corporation (“Holdings”), the Subsidiary Guarantors party hereto, BANK OF AMERICA, N.A.
(“BANA”), as administrative agent (in such capacity, the “Administrative Agent”) and Incremental Term Lender (the “Incremental Term B-3 Lender”) under the Credit Agreement, dated as of
September 28, 2012 (as amended by Amendment No. 1, dated as of February 6, 2013, Amendment No. 2, dated as of February 20, 2013, Amendment No. 3, dated as of February 28, 2013, Amendment No. 4 dated as of
February 20, 2014 and Amendment No. 5, dated as of February 20, 2015, the “Credit Agreement”), among the Parent Borrower, the Co-Borrower, Holdings, BANA, as administrative agent under the Loan Documents, Swing Line
Lender and L/C Issuer, each lender from time to time party thereto (collectively, the “Lenders” and individually, a “Lender”), and the other parties thereto from time to time. Capitalized terms used and not
otherwise defined herein shall have the meanings assigned to them in the Credit Agreement. 
 WHEREAS, BANA, Goldman Sachs Bank USA, J.P.
Morgan Securities LLC, Deutsche Bank Securities Inc. and TPG Capital BD, LLC are acting as Lead Arrangers for this Amendment (collectively, the “Amendment No. 6 Lead Arrangers”); 

WHEREAS, subject to the terms and conditions of the Credit Agreement, the Parent Borrower may establish Incremental Term Commitments with new
and/or existing Term Lenders; 
 WHEREAS, the Parent Borrower has requested, on behalf of itself and the Co-Borrower, that the initial
Incremental Term B-3 Lender party hereto extend credit to the Borrowers in an aggregate principal amount of $425,000,000 in the form of a new Class of Incremental Term Commitments (the “Term B-3 Commitments” and the Incremental Term
Loans with respect to such Commitments, the “Term B-3 Loans”) under the Credit Agreement having identical terms with and having the same rights and obligations under the Loan Documents as the Term B-2 Loans, except as expressly set
forth herein; 
 WHEREAS, subject to the terms and conditions of the Credit Agreement, the Incremental Term B-3 Lender shall become a Lender
pursuant to a joinder agreement substantially in the form of Exhibit A (the “Joinder Agreement”); 
 NOW, THEREFORE, in
consideration of the premises and covenants contained herein and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound hereby, agree as follows:

  

	 	Section 1.	Amendments. 

 Effective as of the Amendment No. 6 Effective Date, the Credit
Agreement is hereby amended as follows: 
 (a) The following defined terms shall be added to Section 1.01 of the Credit Agreement in
alphabetical order: 
 “Amendment No. 6” means Amendment No. 6 to this Agreement dated as of
February 25, 2015. 

 “Amendment No. 6 Effective Date” means February 25,
2015, the date on which all conditions precedent set forth in Section 3 of Amendment No. 6 are satisfied. 

“Amendment No. 6 Lead Arrangers” means, collectively, Bank of America, N.A., Goldman Sachs Bank USA, J.P.
Morgan Securities LLC, Deutsche Bank Securities Inc. and TPG Capital BD, LLC. 
 “Term B-3 Commitment”
means, with respect to each Term B-3 Lender, the obligation of such Term B-3 Lender to make a Term B-3 Loan on the Amendment No. 6 Effective Date, in the amount set forth on the joinder agreement of such Term B-3 Lender to Amendment No. 6,
as such commitment may be (a) reduced from time to time pursuant to Section 2.06 and (b) reduced or increased from time to time pursuant to (i) assignments by or to such Term Lender pursuant to an Assignment and Assumption,
(ii) an Incremental Amendment, (iii) a Refinancing Amendment or (iv) an Extension. The aggregate amount of Term B-3 Commitments as of the Amendment No. 6 Effective Date shall equal $425,000,000. 

“Term B-3 Lender” means a Person with a Term B-3 Commitment to make Term B-3 Loans to the Borrowers on the
Amendment No. 6 Effective Date, which for the avoidance of doubt may be an existing Term Lender. 
 “Term B-3
Loan” means a Loan that is made pursuant to Section 2.01(e) of the Credit Agreement on the Amendment No. 6 Effective Date. 

(b) The definition of “Applicable Rate” in Section 1.01 of the Credit Agreement is hereby amended by deleting such clause in
its entirety and replacing it with the following: 
 “Applicable Rate” means a percentage per annum equal to: 

 

	 	(a)	with respect to Term B-2 Loans, (i) 3.00% for Eurocurrency Rate Loans, and (ii) 2.00% for Base Rate Loans, 

  

	 	(b)	with respect to Term B-3 Loans, (i) 3.25% for Eurocurrency Rate Loans, and (ii) 2.25% for Base Rate Loans, and 

  

	 	(c)	with respect to Tranche A Revolving Credit Loans and unused Tranche A Revolving Credit Commitments, (i) until delivery of financial statements for the first full fiscal quarter commencing on or after the Closing
Date pursuant to Section 6.01, (A) for Eurocurrency Rate Loans, 3.75%, (B) for Base Rate Loans, 2.75%, and (C) for unused commitment fees payable pursuant to Section 2.09(a), 0.50%, and (ii) thereafter, the following
percentages per annum, based upon the Senior Secured Net Leverage Ratio as specified in the most recent Compliance Certificate received by the Administrative Agent pursuant to Section 6.02(a): 

 

															
	 Applicable Rate
	 
	 Pricing Level
	  	 Senior Secured Net

Leverage Ratio
	  	Eurocurrency Rate	 	 	Base Rate	 	 	Commitment Fee
Rate	 
	 1
	  	> 3.0 to 1.0	  	 	3.75	% 	 	 	2.75	% 	 	 	0.50	% 
	 2
	  	£ 3.0 to 1.0 and > 2.5 to 1.0	  	 	3.50	% 	 	 	2.50	% 	 	 	0.375	% 
	 3
	  	£ 2.5 to 1.0	  	 	3.25	% 	 	 	2.25	% 	 	 	0.375	% 

  
 -2- 

	 	(d)	with respect to Tranche B Revolving Credit Loans, unused Tranche B Revolving Credit Commitments and Letter of Credit fees, (i) until delivery of financial statements for the first full fiscal quarter commencing on
or after the Amendment No. 3 Effective Date pursuant to Section 6.01, (A) for Eurocurrency Rate Loans, 3.25%, (B) for Base Rate Loans, 2.25%, (C) for Letter of Credit fees, 3.25% and (D) for unused commitment fees
payable pursuant to Section 2.09(a), 0.50%, and (ii) thereafter, with respect to Tranche B Revolving Credit Loans, unused Tranche B Revolving Credit Commitments and Letter of Credit fees, the following percentages per annum, based upon the
Senior Secured Net Leverage Ratio as specified in the most recent Compliance Certificate received by the Administrative Agent pursuant to Section 6.02(a): 

  

															
	 Applicable Rate
	 
	 Pricing Level
	  	 Senior Secured Net

Leverage Ratio
	  	Eurocurrency Rate and
Letter of Credit Fees	 	 	Base Rate	 	 	Commitment Fee
Rate	 
	 1
	  	> 3.0 to 1.0	  	 	3.25	% 	 	 	2.25	% 	 	 	0.50	% 
	 2
	  	£ 3.0 to 1.0 and > 2.5 to 1.0	  	 	3.25	% 	 	 	2.25	% 	 	 	0.375	% 
	 3
	  	£ 2.5 to 1.0	  	 	3.00	% 	 	 	2.00	% 	 	 	0.375	% 

 Any increase or decrease in the Applicable Rate resulting from a change in the Senior Secured Net Leverage
Ratio shall become effective as of the first Business Day immediately following the date a Compliance Certificate is delivered pursuant to Section 6.02(a); provided that “Pricing Level 1” in clauses (b) and (c) above
shall apply as of (x) the first Business Day after the date on which a Compliance Certificate was required to have been delivered but was not delivered, and shall continue to so apply to and including the date on which such Compliance
Certificate is so delivered (and thereafter the pricing level otherwise determined in accordance with this definition shall apply) and (y) at the option of the Administrative Agent or the Required Facility Lenders under the applicable Revolving
Credit Facility, as of the first Business Day after an Event of Default under Section 8.01(a) shall have occurred and be continuing, and shall continue to so apply to but excluding the date on which such Event of Default is cured or waived (and
thereafter the pricing level otherwise determined in accordance with this definition shall apply). 
 (c) The definition of
“Eurocurrency Rate” in Section 1.01 of the Credit Agreement is hereby amended by deleting such clause in its entirety and replacing it with the following: 

“Eurocurrency Rate” means 
  

	 	(a)	 for any Interest Period with respect to a Eurocurrency Rate Loan, the rate per annum equal to (i) the British Bankers Association LIBOR Rate
(“BBA LIBOR”), as published by Reuters (or such other commercially available source providing quotations of BBA LIBOR as may be designated by the Administrative Agent from time to time) at approximately 11:00 a.m., London time, two
(2) London Banking Days prior to the commencement of such Interest Period, for Dollar deposits (for delivery on the first day of such Interest Period) with a term equivalent to such Interest Period or (ii) if such published rate is not
available at such time for any reason, then the “Eurocurrency Rate” for such Interest Period shall be the rate per annum determined by the Administrative Agent to be the rate at which deposits in Dollars for delivery on the first day of
such Interest Period in Same Day Funds in the approximate amount of the Eurocurrency Rate Loan being made, continued or converted and with a term equivalent to such Interest Period would be offered by the Administrative Agent’s London Branch to

  
 -3- 

	 	
major banks in the London interbank eurodollar market at their request at approximately 11:00 a.m. (London time) two (2) London Banking Days prior to the commencement of such Interest
Period; and 

  

	 	(b)	for any interest calculation with respect to a Base Rate Loan on any date, the rate per annum equal to (i) BBA LIBOR, at approximately 11:00 a.m., London time determined two (2) London Banking Days prior to
such date for Dollar deposits being delivered in the London interbank market for a term of one month commencing that day or (ii) if such published rate is not available at such time for any reason, the rate per annum determined by the
Administrative Agent to be the rate at which deposits in Dollars for delivery on the date of determination in Same Day Funds in the approximate amount of the Base Rate Loan being made or maintained and with a term equal to one month would be offered
by the Administrative Agent’s London Branch to major banks in the London interbank eurodollar market at their request at the date and time of determination; 

provided that the Eurocurrency Rate with respect to Term B-2 Loans and Term B-3 Loans that bear interest at a rate based on clause (a) of this
definition will be deemed not to be less than 1.00% per annum. 
 (d) The definition of “Repricing Transaction” in
Section 1.01 of the Credit Agreement is hereby amended by deleting such clause in its entirety and replacing it with the following: 

“Repricing Transaction” shall mean (i) the prepayment, refinancing, substitution or replacement of all or a portion of
the Term B-3 Loans with the incurrence by the Borrower or any Subsidiary of any debt financing, the primary purpose of which is to reduce the All-In Yield of such debt financing relative to the Term B-3 Loans so repaid, refinanced, substituted or
replaced and (ii) any amendment to this Agreement the primary purpose of which is to reduce the All-In Yield applicable to the Term B-3 Loans. 

(e) The definition of “Base Rate” in Section 1.01 of the Credit Agreement is hereby amended by adding “and Term B-3
Loans” immediately after “Term B-2 Loans” in the proviso thereof; 
 (f) The definition of “Class” in
Section 1.01 of the Credit Agreement is hereby amended by (i) adding “Term B-3 Commitments,” immediately after “Term B-2 Commitments,” in clause (b) and (ii) adding “Term B-3 Loans,” immediately
after “Term B-2 Loans,” in clause (c); 
 (g) The definition of “Commitment” in Section 1.01 of the Credit
Agreement is hereby amended by adding “Term B-3 Commitment,” immediately after “Term B-2 Commitment,”; 
 (h) The
definition of “Facility” in Section 1.01 of the Credit Agreement is hereby amended by adding “Term B-3 Loans,” immediately after “Term B-2 Loans,”; 

(i) Clause (i) of the definition of “Maturity Date” in Section 1.01 of the Credit Agreement is hereby amended by adding
“and Term B-3 Loans” immediately after “Term B-2 Loans”; 
 (j) The definition of “Term Loan” in
Section 1.01 of the Credit Agreement is hereby amended by adding “Term B-3 Loan,” immediately after “Term B-2 Loan,”; 

  
 -4- 

 (k) Section 2.01 of the Credit Agreement is hereby amended by adding the following paragraph
(e) to such Section: 
 “(e) Subject to the terms and conditions set forth herein and in Amendment No. 6, each
Term B-3 Lender severally agrees to make a Term B-3 Loan to the Borrowers on the Amendment No. 6 Effective Date in the principal amount equal to its Term B-3 Commitment on the Amendment No. 6 Effective Date. Amounts borrowed under this
Section 2.01(e) and repaid or prepaid may not be reborrowed. Term B-3 Loans may be Base Rate Loans or Eurocurrency Loans, as further provided herein. All Term B-3 Loans made on the Amendment No. 6 Effective Date by Term B-3 Lender will
have the Type of Loan and Interest Period specified in the Request for Credit Extension delivered in connection therewith (notwithstanding the required periods set forth in the definition of Interest Period).” 

(l) Section 2.05(a) of the Credit Agreement is hereby amended by adding the following sentence to the end of clause (i) thereof:

 “Notwithstanding the foregoing, voluntary prepayments shall be made pro rata among the Term B-2 Loans and Term B-3 Loans.” 

(m) Section 2.05(a) of the Credit Agreement is hereby amended by deleting clause (vi) in its entirety and replacing it with the
following: 
 “(vi) Notwithstanding the foregoing, in the event that, on or prior to the date which is six (6) months after the
Amendment No. 6 Effective Date, any Borrower (x) prepays, refinances, substitutes or replaces any Term B-3 Loans pursuant to a Repricing Transaction (including, for avoidance of doubt, any prepayment made pursuant to
Section 2.05(b)(iii) that constitutes a Repricing Transaction), or (y) effects any amendment of this Agreement resulting in a Repricing Transaction, the Parent Borrower shall pay to the Administrative Agent, for the ratable account of each
of the applicable Term Lenders, (I) in the case of clause (x), a prepayment premium of 1.00% of the aggregate principal amount of the Term B-3 Loans so prepaid, refinanced, substituted or replaced and (II) in the case of clause (y), a fee equal
to 1.00% of the aggregate principal amount of the applicable Term B-3 Loans outstanding immediately prior to such amendment. Such amounts shall be due and payable on the date of effectiveness of such Repricing Transaction.” 

(n) Section 2.05(b) of the Credit Agreement is hereby amended by adding the following sentence to the end of clause (v) thereof:

 “Notwithstanding the foregoing, mandatory prepayments shall be made pro rata among the Term B-2 Loans and Term B-3 Loans.” 

(o) Section 2.06(b) of the Credit Agreement is hereby amended by adding the following sentences to the end of such Section: 

“The Term B-3 Commitment of each Term B-3 Lender shall be automatically and permanently reduced to $0 upon the funding of Term B-3 Loans
to be made by it on the Amendment No. 6 Effective Date.” 

  
 -5- 

 (p) Section 2.07 of the Credit Agreement is hereby amended by adding new clause (d) at
the end: 
 “(d) Term B-3 Loans. The Borrowers shall, jointly and severally, repay to the Administrative Agent
for the ratable account of the Appropriate Lenders (A) on the last Business Day of each March, June, September and December commencing with last Business Day of March 2015, an aggregate principal amount equal to 0.25% of the aggregate principal
amount of all Term B-3 Loans outstanding on the Amendment No. 6 Effective Date (which payments shall be reduced as a result of the application of prepayments in accordance with the order of priority set forth in Section 2.05) and
(B) on the Maturity Date for the Term B-3 Loans, the aggregate principal amount of all Term B-3 Loans outstanding on such date.” 

(q) Section 6.15 of the Credit Agreement is hereby amended by adding “and Term B-3 Loans” immediately after “Term B-2
Loans”; 
 (r) Section 6.16 of the Credit Agreement is hereby amended by deleting such Section in its entirety and replacing it
with the following: 
 “SECTION 6.16. Use of Proceeds. Use the proceeds (a) of any Borrowing on the Closing
Date, whether directly or indirectly, in a manner consistent with the uses set forth in the preliminary statements to this Agreement and after the Closing Date use the proceeds of any Borrowing for general corporate purposes and working capital
needs, (b) with respect to Term B-1 Loans, to refinance the Term B Loans and to pay fees and expenses in connection thereto, (c) with respect to Term B-2 Loans, to refinance the Term B-1 Loans and to pay fees and expenses in connection
thereto and (d) with respect to the Term B-3 Loans, to pay a dividend to the Parent Borrower’s indirect equity holders and to pay fees and expenses in connection thereto. 

 

	 	Section 2.	Representations and Warranties. 

 Each Loan Party represents and warrants to the
Lenders as of the date hereof and the Amendment No. 6 Effective Date that: 
 (a) Before and after giving effect to this Amendment, the
representations and warranties of the Parent Borrower and each other Loan Party contained in Article V of the Credit Agreement or any other Loan Document shall be true and correct in all material respects on and as of the Amendment No. 6
Effective Date; provided that, to the extent that such representations and warranties specifically refer to an earlier date, they shall be true and correct in all material respects as of such earlier date; provided, further,
that, any representation and warranty that is qualified as to “materiality,” “Material Adverse Effect” or similar language shall be true and correct (after giving effect to any qualification therein) in all respects on such
respective date. 
 (b) At the time of and after giving effect to this Amendment, no Default shall exist, or would result from the Amendment
and related Credit Extension or from the application of the proceeds therefrom. 
  

	 	Section 3.	Conditions to Effectiveness. 

 This Amendment shall become effective on the date
on which each of the following conditions is satisfied: 
 (a) The Administrative Agent’s receipt of the following, each of which shall
be originals or facsimiles or electronic copies (followed promptly by originals) unless otherwise specified: 
 (1)
counterparts of this Amendment executed by (A) each Loan Party and (B) the Administrative Agent; 

  
 -6- 

 (2) counterparts of the Joinder Agreement executed by (A) the Parent
Borrower, (B) the Administrative Agent and (C) the Incremental Term B-3 Lender; and 
 (3) a Note executed by the
relevant Borrowers in favor of each Lender requesting a Note at least two (2) Business Days prior to the Amendment No. 6 Effective Date, if any. 

(b) The Administrative Agent’s receipt of the following, each of which shall be originals or facsimiles or electronic copies (followed
promptly by originals) unless otherwise specified; 
 (1) an opinion of (i) Ropes & Gray LLP, New York counsel
to the Loan Parties and (ii) Porzio, Bromberg & Newman, P.C., New Jersey counsel to the Loan Parties, each dated the Amendment No. 6 Effective Date and addressed to the Administrative Agent and the Lenders, in a form reasonably
satisfactory to the Administrative Agent; 
 (2) (A) certificates of good standing (to the extent such concept exists in such
Loan Party’s state of organization) from the applicable secretary of state of the state of organization of each Loan Party, and (B) a certificate of a Responsible Officer of each Loan Party dated the Amendment No. 6 Effective Date and
certifying (I) to the effect that (w) attached thereto is a true and complete copy of the certificate or articles of incorporation or organization such Loan Party certified as of a recent date by the secretary of state of the state of its
organization, or in the alternative, certifying that such certificate or articles of incorporation or organization have not been amended since the Closing Date, and that such certificate or articles are in full force and effect, (x) attached
thereto is a true and complete copy of the by-laws or operating agreements of each Loan Party as in effect on the Amendment No. 6 Effective Date, or in the alternative, certifying that such by-laws or operating agreements have not been amended
since the Closing Date and (y) attached thereto is a true and complete copy of resolutions duly adopted by the board of directors of each Loan Party authorizing the execution, delivery and performance of the Loan Documents to which such Loan
Party is a party, and that such resolutions have not been modified, rescinded or amended and are in full force and effect, and (II) as to the incumbency and specimen signature of each officer executing any Loan Document on behalf of any Loan Party
and signed by another officer as to the incumbency and specimen signature of the Responsible Officer executing the certificate pursuant to this clause (B); and 

(3) a certificate signed by a Responsible Officer of the Parent Borrower certifying that (x) before and after giving
effect to this Amendment, the representations and warranties of the Parent Borrower and each other Loan Party contained in Article V of the Credit Agreement or any other Loan Document shall be true and correct in all material respects on and as of
the Amendment No. 6 Effective Date; provided that, to the extent that such representations and warranties specifically refer to an earlier date, they shall be true and correct in all material respects as of such earlier date;
provided, further, that, any representation and warranty that is qualified as to “materiality,” “Material Adverse Effect” or similar language shall be true and correct (after giving effect to any qualification
therein) in all respects on such respective date and (y) at the time of and after giving effect to this Amendment, no Default shall exist, or would result from the Amendment and related Credit Extension or from the application of the proceeds
therefrom. 
 (4) Copies of a recent Lien and judgment search in the jurisdiction of organization of each Loan Party, as
reasonably requested by the Administrative Agent with respect to the Loan Parties. 

  
 -7- 

 (c) The Administrative Agent shall have received a completed “Life-of-Loan” Federal
Emergency Management Agency Standard Flood Hazard Determination with respect to the Mortgaged Property located in the United States as of the Amendment No. 6 Effective Date (together with a notice about special flood hazard area status and
flood disaster assistance duly executed by the Parent Borrower and the applicable Loan Party relating thereto, if required) and, if any such Mortgaged Property is located in a special flood hazard area, evidence of flood insurance to the extent
required pursuant to the Credit Agreement. 
 (d) All fees and expenses due to the Administrative Agent and the Amendment No. 6 Lead
Arrangers (including, without limitation, pursuant to Section 4 hereof) required to be paid on the Amendment No. 6 Effective Date and invoiced at least two (2) Business Days prior to the Amendment No. 6 Effective Date shall have
been paid. 
 (e) To the extent reasonably requested by the Incremental Term B-3 Lender in writing not less than five (5) Business Days
prior to the Amendment No. 6 Effective Date, the Administrative Agent shall have received, prior to the effectiveness of this Amendment, all documentation and other information with respect to the Parent Borrower required by regulatory
authorities under applicable “know-your-customer” and anti-money laundering rules and regulations, including the PATRIOT Act. 

(f) The Administrative Agent shall have received a Request for Credit Extension not later than 1:00 p.m. on the Business Day prior to the date
of the proposed Credit Extension. 
 The Administrative Agent shall notify the Parent Borrower and the Lenders of the Amendment No. 6
Effective Date and such notice shall be conclusive and binding. 
  

	 	Section 4.	Expenses. 

 The Parent Borrower agrees to reimburse the Administrative Agent for
its reasonable and documented out-of-pocket expenses incurred by it in connection with this Amendment, including the reasonable fees, charges and disbursements of Cahill Gordon & Reindel LLP, counsel for the Administrative
Agent. 
  

	 	Section 5.	Counterparts. 

 This Amendment may be executed in counterparts (and by different
parties hereto in different counterparts), each of which shall constitute an original, but all of which when taken together shall constitute a single contract. Delivery of an executed counterpart of a signature page of this Amendment by facsimile
transmission or other electronic imaging means shall be effective as delivery of a manually executed counterpart of this Amendment. 
  

	 	Section 6.	Governing Law and Waiver of Right to Trial by Jury. 

 THIS AMENDMENT SHALL BE
GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAW OF THE STATE OF NEW YORK. The jurisdiction and waiver of right to trial by jury provisions in Section 10.16 and 10.17 of the Credit Agreement are incorporated herein by reference mutatis
mutandis. 

  
 -8- 

	 	Section 7.	Headings. 

 The headings of this Amendment are for purposes of reference only and
shall not limit or otherwise affect the meaning hereof. 
  

	 	Section 8.	Reaffirmation. 

 Each Loan Party hereby expressly acknowledges the terms of this
Amendment and reaffirms, as of the date hereof, (i) the covenants and agreements contained in each Loan Document to which it is a party, including, in each case, such covenants and agreements as in effect immediately after giving effect to this
Amendment and the transactions contemplated hereby and (ii) its guarantee of the Obligations (including, without limitation, in respect of the Term B-3 Loans) under the Guaranty, as applicable, and its grant of Liens on the Collateral to secure
the Obligations (including, without limitation, in respect of the Term B-3 Loans) pursuant to the Collateral Documents. For the avoidance of doubt, on and after the Amendment No. 6 Effective Date, this Amendment shall for all purposes
constitute a Loan Document. 
  

	 	Section 9.	Effect of Amendment; References to the Credit Agreement. 

 Except as expressly set
forth herein, this Amendment shall not by implication or otherwise limit, impair, constitute a waiver of or otherwise affect the rights and remedies of the Lenders or the Agents under the Credit Agreement or any other Loan Document, and shall not
alter, modify, amend or in any way affect any of the terms, conditions, obligations, covenants or agreements contained in the Credit Agreement or any other provision of the Credit Agreement or any other Loan Document, all of which are ratified and
affirmed in all respects and shall continue in full force and effect. All references to the Credit Agreement in any document, instrument, agreement, or writing shall from and after the Amendment No.6 Effective Date be deemed to refer to the Credit
Agreement as amended hereby, and, as used in the Credit Agreement, the terms “Agreement,” “herein,” “hereafter,” “hereunder,” “hereto” and words of similar import shall mean, from and after the
Amendment No. 6 Effective Date, the Credit Agreement as amended hereby. 
  

	 	Section 10.	FATCA.

 For purposes of determining withholding Taxes imposed under the Foreign
Account Tax Compliance Act (FATCA), the Borrowers and the Administrative Agent shall treat (and the Incremental Term B-3 Lender hereby authorizes the Administrative Agent to treat) the Term B-3 Loans as not qualifying as “grandfathered
obligations” within the meaning of Treasury Regulation Section 1.1471-2(b)(2)(i). 
 [Signature Pages Follow] 

  
 -9- 

 IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be duly executed as of the
date first above written. 
  

					
	SKY GROWTH INTERMEDIATE HOLDINGS II CORPORATION, as Holdings
		
	By:		 /s/ Michael A. Tropiano

			Name:		Michael A. Tropiano
			Title:		 Executive Vice President and
 Chief Financial
Officer

	
	PAR PHARMACEUTICAL COMPANIES, INC., as the Parent Borrower
		
	By:		 /s/ Michael A. Tropiano

			Name:		Michael A. Tropiano
			Title:		 Executive Vice President and
 Chief Financial
Officer

	
	PAR PHARMACEUTICAL, INC., as the Co-Borrower
		
	By:		 /s/ Michael A. Tropiano

			Name:		Michael A. Tropiano
			Title:		 Executive Vice President and
 Chief Financial
Officer

	
	 PAR, INC
 KALI
LABORATORIES, INC.,
 ANCHEN INCORPORATED

	 ANCHEN PHARMACEUTICALS, INC.

JHP GROUP HOLDINGS, INC.
 JHP ACQUISITION,
LLC

	PAR STERILE PRODUCTS, LLC, each as a Subsidiary Guarantor
		
	By:		 /s/ Michael A. Tropiano

			Name:		Michael A. Tropiano
			Title:		 Executive Vice President and
 Chief Financial
Officer

  
 [Amendment No. 6] 

 
					
	BANK OF AMERICA, N.A., as Administrative Agent
		
	By:		 /s/ Don B. Pinzon

			Name:		Don B. Pinzon
			Title:		Vice President

  
 [Amendment No. 6] 

 
					
	BANK OF AMERICA, N.A., as Incremental Term B-3 Lender
		
	By:		 /s/ Douglas Ingram

			Name:		Douglas Ingram
			Title:		Managing Director

  
 [Amendment No. 6] 

 EXHIBIT A 

JOINDER AGREEMENT 

JOINDER AGREEMENT, dated as of [—],
20[—] (this “Agreement”), by and among [TERM B-3 LENDER] (the “Term B-3 Lender”), PAR PHARMACEUTICAL COMPANIES, INC.
(the “Parent Borrower”), and BANK OF AMERICA, N.A. (the “Administrative Agent”). 
 RECITALS: 

WHEREAS, reference is hereby made to the Credit Agreement, dated as of September 28, 2012, as amended prior to the date hereof and as
amended by Amendment No. 6 dated as of February 25, 2015 (the “Amendment”) (as further as amended, restated, modified or supplemented from time to time, the “Credit Agreement”), among the Parent Borrower,
PAR PHARMACEUTICAL, INC., a Delaware corporation (the “Co-Borrower” and, together with the Parent Borrower, the “Borrowers” and each a “Borrower”), SKY GROWTH INTERMEDIATE HOLDINGS II CORPORATION, a
Delaware corporation (“Holdings”), the Subsidiary Guarantors party thereto and BANK OF AMERICA, N.A., as Administrative Agent, Swing Line Lender and L/C Issuer, each lender from time to time party thereto (collectively, the
“Lenders” and individually, a “Lender”), and the other parties thereto from time to time (capitalized terms used but not defined herein having the meaning provided in the Credit Agreement); 

WHEREAS, subject to the terms and conditions of the Credit Agreement, the Parent Borrower may establish Incremental Term Commitments (the
“Term B-3 Commitments”) with the Term B-3 Lender (which, for the avoidance of doubt, may be an existing Term Lender); and 

WHEREAS, subject to the terms and conditions of the Credit Agreement, the Term B-3 Lender shall become a Lender pursuant to one or more
joinder agreements; 
 NOW, THEREFORE, in consideration of the premises and agreements, provisions and covenants herein contained, the
parties hereto agree as follows: 
 On the Amendment No. 6 Effective Date, the Term B-3 Lender hereby irrevocably and unconditionally
approves the Amendment to the Credit Agreement and agrees to provide the Term B-3 Commitment set forth on its signature page hereto pursuant to and in accordance with Section 2.01(e) of the Credit Agreement. The Term B-3 Commitment provided
pursuant to this Agreement shall be subject to all of the terms in the Credit Agreement and to the conditions set forth in the Credit Agreement, and shall be entitled to all the benefits afforded by the Credit Agreement and the other Loan Documents,
and shall, without limiting the foregoing, benefit equally and ratably from the Guarantees and security interests created by the Collateral Documents. For the avoidance of doubt, the Term B-3 Lender hereby consents to Amendment No. 6 to the
Credit Agreement. 
 The Term B-3 Lender, the Parent Borrower and the Administrative Agent acknowledge and agree that the Term B-3
Commitment provided pursuant to this Agreement shall constitute Incremental Term Commitments for all purposes of the Credit Agreement and the other applicable Loan Documents. The Term B-3 Lender hereby agrees to make the Term B-3 Loan to the
Borrowers in an amount equal to its Term B-3 Commitment on the Amendment No. 6 Effective Date in accordance with Section 2.01(e) of the Credit Agreement. 

The Term B-3 Lender (i) confirms that it has received a copy of the Credit Agreement, and has received or has been accorded the
opportunity to receive copies of the most recent financial statements delivered pursuant to Section 6.01(a) and (b) thereof, as applicable, and such other documents and information as it has deemed appropriate to make its own credit
analysis and decision to enter into 

 
this Agreement; (ii) agrees that it will, independently and without reliance upon the Administrative Agent, the Amendment No. 6 Lead Arrangers or any other Lender or Agent and based on
such documents and information as it shall deem appropriate at the time, continue to make its own credit decisions in taking or not taking action under the Credit Agreement; (iii) appoints and authorizes the Administrative Agent to take such
action as agent on its behalf and to exercise such powers and discretion under the Credit Agreement and the other Loan Documents as are delegated to the Administrative Agent by the terms thereof, together with such powers and discretion as are
reasonably incidental thereto; and (iv) agrees that it will perform in accordance with their terms all of the obligations which by the terms of the Credit Agreement are required to be performed by it as a Lender. 

Upon (i) the execution of a counterpart of this Agreement by the Term B-3 Lender, the Administrative Agent and the Parent Borrower and
(ii) the delivery to the Administrative Agent of a fully executed counterpart (including by way of telecopy or other electronic transmission) hereof, the Term B-3 Lender shall become a Lender under the Credit Agreement and shall have the
respective Term B-3 Commitment set forth on its signature page hereto, effective as of the Amendment No. 6 Effective Date. 
 Delivered
herewith to the Administrative Agent or the Parent Borrower, as applicable, are such forms, certificates or other evidence with respect to United States federal income tax withholding matters as the Term B-3 Lender may be required to deliver to the
Administrative Agent or the Parent Borrower, as applicable, pursuant to Section 3.01 of the Credit Agreement. 
 For purposes of
determining withholding Taxes imposed under the Foreign Account Tax Compliance Act (FATCA), the Borrowers and the Administrative Agent shall treat (and the Term B-3 Lender hereby authorizes the Administrative Agent to treat) the Term B-3 Loan as not
qualifying as a “grandfathered obligation” within the meaning of Treasury Regulation Section 1.1471-2(b)(2)(i). 
 This
Agreement may not be amended, modified or waived except by an instrument or instruments in writing signed and delivered on behalf of each of the parties hereto. 

As of the Amendment No. 6 Effective Date, this Agreement, the Credit Agreement and the other Loan Documents constitute the entire
agreement among the parties with respect to the subject matter hereof and thereof and supersede all other prior agreements and understandings, both written and verbal, among the parties or any of them with respect to the subject matter hereof. 

THIS AGREEMENT SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK. 

If any provision of this Agreement is held to be illegal, invalid or unenforceable, (a) the legality, validity and enforceability of the
remaining provisions of this Agreement shall not be affected or impaired thereby and (b) the parties shall endeavor in good faith negotiations to replace the illegal, invalid or unenforceable provisions with valid provisions the economic effect
of which comes as close as possible to that of the illegal, invalid or unenforceable provisions. The invalidity of a provision in a particular jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction. 

This Agreement may be executed in counterparts (and by different parties hereto in different counterparts), each of which shall constitute an
original, but all of which when taken together shall constitute a single contract. Delivery of an executed counterpart of a signature page of this Agreement by facsimile transmission or other electronic imaging means shall be effective as delivery
of a manually executed counterpart of this Agreement. 
 [Signature Pages Follow] 

  
 A-2 

 IN WITNESS WHEREOF, each of the undersigned has caused its duly authorized officer to execute and
deliver this Agreement as of the date first mentioned above. 
  

			
	[TERM B-3 LENDER], as Term B-3 Lender
		
	By:		  

			Name:
			Title:
	
	If a second signature is necessary:
		
	By:		  

			Name:
			Title:
	
	Term B-3 Commitment:
	
	$[            ]

  
 A-3 

 
			
	PAR PHARMACEUTICAL COMPANIES, INC.
		
	By:		  

			Name:
			Title:

  
 A-4 

			
	 Accepted:
  

BANK OF AMERICA, N.A.,
 as Administrative Agent

		
	By:		  

			Name:
			Title:

  
 A-5EX-10.1

 Exhibit 10.1 

EMPLOYMENT TRANSITION AND CONSULTING AGREEMENT 

This Employment Transition and Consulting Agreement (this “Agreement”), effective as of the Effective Date (as defined
below), is entered into by and among BioMed Realty Trust, Inc., a Maryland corporation (the “REIT”), BioMed Realty, L.P., a Maryland limited partnership (the “Operating Partnership,” and together with the REIT, the
“Company”), and Kent Griffin (“Executive”), and inures to the benefit of each of the Company’s current, former and future parents, subsidiaries, related entities, employee benefit plans and their fiduciaries,
predecessors, successors, officers, directors, shareholders, agents, employees and assigns. 
 WHEREAS, Executive is currently employed by
the Company as its President and Chief Operating Officer, and is a party to that certain Change in Control and Severance Agreement executed effective January 25, 2012, by and among the REIT, the Operating Partnership and Executive (the
“Change in Control and Severance Agreement”); 
 WHEREAS, both Executive and the Company have determined that it is in
their mutual best interests that Executive’s employment with the Company terminate, and that their employment relationship be dissolved in the manner set forth in this Agreement; 

WHEREAS, both Executive and the Company have determined that it is in their mutual best interests that Executive continue to provide
consulting services to the Company following his termination of employment; and 
 WHEREAS, Executive and the Company desire to set forth
the terms and conditions of the foregoing arrangement. 
 NOW, THEREFORE, in consideration of the mutual promises herein contained, the
parties agree as follows: 
 1. Effective Date; Termination of Employment. 

(a) Effective Date. This Agreement shall become effective upon the occurrence of both of the following events: (i) execution of the
Agreement by the parties hereto and the execution of the Release (as defined in Section 3(e) below) by Executive; and (ii) expiration of the revocation period applicable under the Release without Executive having given notice of
revocation. The date of the last to occur of the foregoing events shall be referred to in this Agreement as the “Effective Date.” Until and unless both of the foregoing events occur, this Agreement shall be null and void. 

(b) Termination of Employment Status. Executive’s employment by the Company shall terminate effective as of February 25, 2015
(the “Termination Date”). Executive hereby resigns from his position as President and Chief Operating Officer (and any other titles or officer positions he may hold) of the Company (and any of its Affiliates (as defined below))
effective as of the Termination Date. Executive shall execute any additional documentation necessary to effectuate such resignations. 

 2. Consulting Services. 

(a) Consulting Period. Subject to earlier termination pursuant to Section 5 below, Executive will provide consulting services to
the Company during the period (the “Consulting Period”) commencing on the Termination Date and ending on January 1, 2018. Upon termination of the Consulting Period, Executive shall use commercially reasonable efforts to
minimize fees and expenses upon termination and ensure the smooth transfer of the work performed by Executive to the relevant Company representative. 

(b) Scope of Services During Consulting Period. The scope of Executive’s consulting services (the “Services”)
shall include, but is not necessarily limited to, consulting with the Company on strategic, investment and advisory activities including advisory services associated with BioMed Ventures. 

(c) Standard for Performance. Executive shall use commercially reasonable efforts in performing the Services under this Agreement, which
shall be conducted with due diligence, good faith and in full compliance with the highest professional standards of practice in the industry. Executive shall comply with all applicable laws and any Company requirements in the course of performing
the Services. If Executive’s work requires a license, Executive has obtained that license and the license is in full force and effect. 

(d) Availability. In connection with Executive’s Services to the Company, Executive agrees to: (i) be available for
consultation by telephone, fax or e-mail on reasonable prior notice; and (ii) be available to attend meetings with the Chief Executive Officer or Chief Financial Officer of the Company (each, an “Authorized Officer”), or
persons designated by any of the foregoing Authorized Officers, at the Company’s headquarters or other offices, on reasonable prior notice. 

(e) Status as Consultant. Notwithstanding any provision of this Agreement to the contrary, during the Consulting Period, Executive
acknowledges that he is and shall at all times be an independent contractor, he is not an agent or employee of the Company and he is not authorized to bind the Company or otherwise act on behalf of the Company. Nothing herein contained shall be
deemed to create an agency, joint venture, partnership or franchise relationship between the parties hereto. After the Termination Date, Executive shall have no right under this Agreement, or as a result of his Services to the Company, to
participate in any employee, retirement, insurance or other benefit program of the Company (except to the extent Executive elects to and is eligible to receive continued healthcare coverage pursuant to the provisions of the Consolidated Omnibus
Budget Reconciliation Act of 1985, as amended (“COBRA”), for himself and any covered dependents), nor will the Company make any deductions from Executive’s compensation for taxes, the payment of which shall be solely
Executive’s responsibility. Executive represents and warrants that neither this Agreement nor the performance thereof will conflict with or violate any obligation of Executive or right of any third party. This Agreement does not limit the
authority of the Company to enter into other contracts with other independent contractors. Consistent with Executive’s status as an independent contractor during the Consulting Period, this Agreement does not preclude Executive from providing
consulting or other services as an independent contractor or from commencing employment with any other entity, consistent with his obligations under this Agreement. 

  
 2 

 3. Compensation. 

(a) Compensation through Termination Date. On the Termination Date, the Company shall issue Executive his final paycheck, reflecting:
(i) his earned but unpaid base salary through the Termination Date; (ii) all accrued, unused PTO (vacation and sick leave) due Executive through the Termination Date; and (iii) all outstanding expense reimbursements submitted to the
Company as of the Termination Date. Subject to Sections 3(b) and (c) below, Executive acknowledges and agrees that with his final check, the payment of any additional expense reimbursements submitted after the Termination Date relating to
expenses incurred prior to the Termination Date, and the payment of any amounts payable under any of the employee benefit plans of the Company in accordance with the terms of such plans, Executive will have received all monies, bonuses, commissions,
expense reimbursement, vacation pay, or other compensation he earned or was due during his employment by the Company. 
 (b)
Severance. In consideration for the Release and his continued compliance with the terms of this Agreement, Executive shall be entitled to the following severance payments: 

i. Cash severance payments in the aggregate amount of $5,128,711, of which $2,598,477 shall be paid within ten (10) days following the
Effective Date and the remaining $2,530,234 shall be paid on March 1, 2016. Each severance payment shall be subject to all legally required withholdings. 

ii. An aggregate of 126,202 shares of unvested restricted stock granted pursuant to those certain Restricted Stock Awards dated as of
January 25, 2012, January 16, 2013, January 15, 2014 and January 28, 2015, by and between Executive and the REIT, shall vest on the Effective Date. 

Executive acknowledges that the foregoing cash payments and restricted stock acceleration are in full satisfaction of the amounts payable to
him under the Change in Control and Severance Agreement. 
 (c) Compensation during Consulting Period. 

i. Retainer. During the Consulting Period, as compensation for the Services to be rendered pursuant to this Agreement, Executive shall
be entitled to a cash retainer of $10,000 per month, payable in arrears within fifteen (15) days following the end of each calendar month during the Consulting Period. 

ii. Reimbursement of Expenses. During the Consulting Period, the Company shall reimburse Executive for reasonable and pre-approved
out-of-pocket business expenses incurred in connection with the performance of his Services hereunder, subject to (x) a maximum of $25,000 annually, (y) such expense reimbursement policies and procedures as the Company may from time to
time establish and communicate to Executive, and (z) Executive furnishing the Company with evidence in the form of receipts satisfactory to the Company substantiating the claimed expenditures. The Company agrees to reimburse Executive for
amounts payable to Executive under this Section 3(c)(ii) within thirty (30) days after receipt of satisfactory evidence from Executive. 

  
 3 

 iii. Performance Units. There shall be no break in service as a result of
Executive’s conversion from an employee to an independent contractor and consultant for purposes of the vesting of Executive’s outstanding performance units (the “Performance Units”) granted to Executive pursuant to those
certain Performance Unit Award Grant Notice and Performance Unit Award Agreements entered into between the Company and Executive (each, a “Performance Unit Agreement”) dated as of January 16, 2013, January 15, 2014
and January 28, 2015. During the Consulting Period, and subject to Section 5 below, the Performance Units previously issued to Executive shall continue to be eligible to vest in accordance with the terms of the applicable Performance Unit
Agreement. Each of the Performance Unit Agreements is hereby amended to delete Section 2 of Exhibit B thereof. Notwithstanding the foregoing, the Performance Units shall be eligible to vest upon the occurrence of a Change in Control (as defined
in the BioMed Realty Trust, Inc. and BioMed Realty, L.P. 2004 Incentive Award Plan, as amended from time to time, the “Plan”) during the Consulting Period in accordance with the terms of the Performance Unit Agreements. Following
the Termination Date, Executive shall not be entitled to any additional grants of stock awards. 
 (d) Exclusive Remedy. Except as
otherwise expressly required by law (e.g., COBRA) or as specifically provided herein, all of Executive’s rights to compensation, benefits, and other amounts hereunder (if any) accruing after the termination of Executive’s employment by or
service to the Company shall cease upon such termination and the related payment of the Executive’s final paycheck as described in Section 3(a). In addition, Executive acknowledges and agrees that he is not entitled to any reimbursement by
the Company for any taxes payable by Executive as a result of the payments and benefits received by Executive pursuant to this Section 3, including, without limitation, any excise tax imposed by Section 4999 of the Internal Revenue Code of
1986, as amended (the “Code”). 
 (e) Release. Executive’s right to receive any of the payments or other
compensation to be made to Executive pursuant to Sections 3(b) and 3(c) shall be contingent on Executive providing to the Company (and failing to revoke) a full and complete general release in the form attached hereto as Exhibit A (the
“Release”). In the event Executive has not signed the Release on or prior to the date that is twenty-one (21) days following the Termination Date, or Executive revokes the Release within the time period specified therein, this
Agreement shall not become effective and the Company shall not be obligated to pay any amounts pursuant to Sections 3(b) and 3(c) to Executive under this Agreement. 

4. Confidential Information and Non-Solicitation. 

(a) Executive shall hold in a fiduciary capacity for the benefit of the Company all secret or confidential information, knowledge or data
relating to the REIT, the Operating Partnership and their respective Affiliates (collectively, the “REIT Group”), and each of their respective businesses, which shall have been obtained by Executive during Executive’s
employment by the Company or during Executive’s Services pursuant to this Agreement and which shall not be or become public knowledge as the result of any acts by Executive or representatives of Executive in violation of this Agreement. After
termination of Executive’s employment and the Consulting Period, Executive shall not, without the prior 

  
 4 

 
written consent of the Company or as may otherwise be required by law or legal process, communicate or divulge any such information, knowledge or data to anyone other than the Company and those
designated by it; provided, that if Executive receives actual notice that Executive is or may be required by law or legal process to communicate or divulge any such information, knowledge or data, Executive shall promptly so notify the Company. 

(b) During the Consulting Period, Executive shall not directly or indirectly solicit, induce, or encourage any employee, consultant, agent,
customer, vendor, or other parties doing business with any member of the REIT Group to terminate their employment, agency, or other relationship with the REIT Group or such member or to render services for or transfer their business from the REIT
Group or such member and Executive shall not initiate discussion with any such person for any such purpose or authorize or knowingly cooperate with the taking of any such actions by any other individual or entity. 

(c) In recognition of the facts that irreparable injury will result to the Company in the event of a breach by Executive of his obligations
under Sections 4(a) and (b) of this Agreement, that monetary damages for such breach would not be readily calculable, and that the Company would not have an adequate remedy at law therefor, Executive acknowledges, consents and agrees that in
the event of such breach, or the threat thereof, the Company shall be entitled, in addition to any other legal remedies and damages available, to specific performance thereof and to temporary and permanent injunctive relief (without the necessity of
posting a bond) to restrain the violation or threatened violation of such obligations by Executive. 
 (d) This Section 4 shall survive
for a period of three (3) years following the termination of Executive’s Services or any expiration or termination of this Agreement, with the exception of Section 4(b) which, pursuant to its terms, expires at the end of the
Consulting Period. 
 5. Termination. 

(a) Other Than For Significant Cause Event. The Company and Executive shall be entitled to terminate this Agreement and the Consulting
Period, for any or no reason, by providing thirty (30) days’ prior written notice to the other party. Upon termination of this Agreement and the Consulting Period by the Company or Executive, other than in connection with a Significant
Cause Event (as defined below), (x) the Company shall remain obligated to make all payments to Executive under Section 3(b); (y) the Company shall cease all payments to Executive under Section 3(c)(i) with the exception of any
retainer for services performed in previous months and any unreimbursed expenses submitted in accordance with Section 3(c)(ii); and (z) the Performance Units shall continue to be eligible to vest on the applicable Determination Date (as
defined in the applicable Performance Unit Agreement), with the exception that the number of Performance Units that shall vest, if any, shall be further multiplied by a fraction (not to exceed one), (i) the numerator of which shall be equal to
the number of whole months (counting each month as ending on the first day of a calendar month) elapsed from the date of commencement of the applicable Performance Period (as defined in the applicable Performance Unit Agreement) until the date of
the termination of Executive’s Services hereunder, and (ii) the denominator of which shall be thirty-six (36). 

  
 5 

 (b) Significant Cause Event. The Company may terminate this Agreement and the Consulting
Period effective immediately upon the occurrence of a Significant Cause Event. Upon termination of this Agreement and the Consulting Period by the Company due to a Significant Cause Event, or by the Company or Executive which is caused by, occurs in
connection with, or is triggered by Executive in advance of or otherwise in order to avoid a determination that there has occurred, or will occur, an event constituting a Significant Cause Event, (x) the Company shall remain obligated to make
all payments to Executive under Section 3(b); (y) the Company shall cease all payments to Executive under Section 3(c)(i) with the exception of any retainer for services performed in previous months and any unreimbursed expenses
submitted in accordance with Section 3(c)(ii); and (z) the Performance Units shall continue to be eligible to vest on the applicable Determination Date (as defined in the applicable Performance Unit Agreement), with the exception that the
number of Performance Units that shall vest, if any, shall be further multiplied by a fraction (not to exceed one), (i) the numerator of which shall be equal to the number of whole months (counting each month as ending on the first day of a
calendar month) elapsed from the date of commencement of the applicable Performance Period (as defined in the applicable Performance Unit Agreement) until the Termination Date, and (ii) the denominator of which shall be thirty-six (36).
“Significant Cause Event” means any of the following, as determined by the Company in its reasonable discretion: (i) Executive’s commission of an act of fraud or material dishonesty or willful misconduct in the performance
of his duties; (ii) Executive’s conviction of, or entry by Executive of a guilty or no contest plea to, the commission of a felony or a crime involving moral turpitude; (iii) Executive’s negligent or willful violation of
applicable law in the performance of the Services; (iv) Executive’s material breach of this Agreement; or (v) Executive, directly or indirectly, consults for, becomes employed by or Affiliated with or otherwise conducts business with
any of the Persons listed on Schedule I hereto or their respective Affiliates (together, the “Defined Competitors”). “Affiliate” means with respect to any Person, any other Person that directly or indirectly
through one or more intermediaries, controls, is controlled by or is under common control with such Person. The term “control” and with correlative meanings, the terms “controlled by” and “under common control
with,” means (x) the possession, directly or indirectly, of the power to direct the management or policies of a Person, whether through the ownership of voting securities or other ownership interests, as an executive officer or director,
or by contract or otherwise, or (y) the ownership, directly or indirectly, of at least fifty percent (50%) of the voting securities or other ownership interests of a Person. “Person” means an individual, partnership, joint
venture, association, corporation, limited liability company and any other form of business organization. 
 6. Nondisparagement.
Executive agrees that neither he nor anyone acting by, through, under or in concert with him shall disparage or otherwise communicate negative statements or opinions about the Company, its directors, officers, partners, employees, agents or
business. The Company agrees that neither its Board members nor officers shall disparage or otherwise communicate negative statements or opinions about Executive. 

7. Arbitration. Except as set forth in Section 4, any disagreement, dispute, controversy or claim arising out of or relating to
this Agreement or the interpretation of this Agreement or any arrangements relating to this Agreement or contemplated in this Agreement or the breach, termination or invalidity thereof shall be settled by final and binding arbitration administered
by JAMS in San Diego County, California in accordance with the then existing 

  
 6 

 
JAMS Arbitration Rules and Procedures for Employment Disputes (the “Rules”). The Rules can be found online at www.jamsadr.org. In the event of such an arbitration proceeding,
Executive and the Company shall use one arbitrator only and will choose the arbitrator from the panel provided by JAMS by either (1) agreement between Executive and the Company or (2) Executive and the Company each striking arbitrators
from the panel provided until JAMS chooses an arbitrator from the remaining names on the list or any secondary list provided to Executive and the Company. Neither Executive nor the Company nor the arbitrator shall disclose the existence, content, or
results of any arbitration hereunder without the prior written consent of all parties. Except as provided herein, the Federal Arbitration Act shall govern the interpretation, enforcement and all proceedings. The arbitrator shall apply the
substantive law (and the law of remedies, if applicable) of the State of California, or federal law, or both, as applicable, and the arbitrator is without jurisdiction to apply any different substantive law. The arbitrator shall have the authority
to entertain a motion to dismiss and/or a motion for summary judgment by any party and shall apply the standards governing such motions under the Federal Rules of Civil Procedure. Executive and the Company will be entitled to engage in reasonable
discovery in the form of requests for production of documents, interrogatories, requests for admission, physical and/or mental examinations and depositions under the standards provided by the Federal Rules of Civil Procedure and Federal Rules of
Evidence. Any disputes concerning discovery shall be resolved by the arbitrator. In these disputes, the arbitrator shall order the additional discovery (if any) which he/she considers necessary to a full and fair exploration of the issues in
dispute, consistent with the expedited nature of arbitration. The arbitrator shall render an award and a written, reasoned opinion in support thereof. Judgment upon the award may be entered in any court having jurisdiction thereof. The Company will
pay the direct costs and expenses of the arbitration, including the cost of any record or transcripts of the arbitration, the JAMS administrative fees, and the fee of the arbitrator. Executive and the Company shall be responsible for their
respective attorneys’ fees incurred in connection with enforcing this Agreement; provided, however, Executive and the Company agree that, except as may be prohibited by law, the arbitrator may, in his or her discretion, award reasonable
attorneys’ fees to the prevailing party; provided, further, that the prevailing party shall be reimbursed for such fees, costs and expenses within sixty (60) days following any such award. This Section 7 is intended to be the
exclusive method for resolving any and all claims by the parties against each other related to any disagreement, dispute, controversy or claim arising out of or relating to this Agreement or the interpretation of this Agreement or any arrangements
relating to this Agreement or contemplated in this Agreement or the breach, termination or invalidity thereof; provided, however, that Executive shall retain the right to file administrative charges with or seek relief through any
government agency of competent jurisdiction, and to participate in any government investigation, including but not limited to (i) claims for workers’ compensation, state disability insurance or unemployment insurance; (ii) claims for
unpaid wages or waiting time penalties brought before the California Division of Labor Standards Enforcement; provided, however, that any appeal from an award or from denial of an award of wages and/or waiting time penalties shall be
arbitrated pursuant to the terms of this paragraph; and (iii) claims for administrative relief from the United States Equal Employment Opportunity Commission and/or the California Department of Fair Employment and Housing (or any similar agency
in any applicable jurisdiction other than California); provided, further, that Executive shall not be entitled to obtain any monetary relief through such agencies other than workers’ compensation benefits or unemployment insurance
benefits. Notwithstanding the foregoing, this Section 7 shall not limit any party’s right to obtain any provisional remedy, including, without limitation, injunctive or similar relief, from any court of competent jurisdiction as may be
necessary to protect their rights and interests pending the outcome of arbitration, including without limitation injunctive relief, in any court of competent jurisdiction pursuant to California Code of Civil Procedure § 1281.8 or any similar
statute of an applicable jurisdiction, 

  
 7 

 
including, without limitation, the Company’s right to enforce Executive’s obligations under Section 4 to the extent the Company is entitled to seek specific performance thereunder.
Seeking any such relief shall not be deemed to be a waiver of such party’s right to compel arbitration. Each of Executive and the Company hereby expressly waive their right to a jury trial. 

8. Litigation Cooperation. Executive agrees to give reasonable cooperation, at the Company’s request, in any pending or future
litigation or arbitration brought against the Company and in any investigation the Company may conduct, including taking such requested actions as are reasonably necessary to preserve the Company’s attorney-client privilege. The Company agrees
to reimburse Executive for his reasonable and pre-approved out-of-pocket expenses incurred in connection with such cooperation within thirty (30) days after receipt of satisfactory evidence from Executive setting forth in reasonable detail such
expenses, as well as for Executive’s time spent assisting the Company after the conclusion of the Consulting Period, including any related travel time; Executive shall be reimbursed at a rate of $300 an hour. Notwithstanding the foregoing, the
Company shall have no obligation by virtue of this Section 8 to pay Executive for time spent by Executive in any pending or future litigation or arbitration where Executive is a co-defendant or party to the arbitration or litigation. 

9. Miscellaneous. 
 (a)
Entire Agreement. This Agreement and the agreements and schedules referenced herein set forth the entire agreement of the parties hereto in respect of the subject matter contained herein and therein and supersede all prior agreements,
promises, covenants, arrangements, communications, representations or warranties, whether oral or written, by any officer, employee or representative of any party hereto, and any prior agreement of the parties hereto in respect of the subject matter
contained herein, including without limitation, any contrary or limiting provisions in any Company equity compensation plan and the Change in Control and Severance Agreement. In addition, this Agreement shall not limit in any way any obligation
Executive may have under any other agreement with or promise to the Company relating to confidentiality, proprietary rights in technology or the assignment of interests in any intellectual property. 

(b) Assignment; Assumption by Successor. Neither this Agreement nor any of the rights or obligations hereunder may be assigned by either
party without the prior written consent of the other party. Notwithstanding the foregoing, the rights of the Company under this Agreement may, without the consent of Executive, be assigned by the Company, in its sole and unfettered discretion, to
any Person which at any time, whether by purchase, merger or otherwise, directly or indirectly, acquires all or substantially all of the assets or business of the Company. Unless expressly provided otherwise, “Company” as used
herein shall mean the Company as defined in this Agreement and any successor to its business and/or assets as aforesaid. 
 (c)
Survival. The covenants, agreements, representations and warranties contained in or made in Sections 3, 4, 5, 6, 7, 8 and 9 of this Agreement shall survive any termination of Executive’s services or any termination of this
Agreement. 

  
 8 

 (d) Third-Party Beneficiaries. This Agreement does
not create, and shall not be construed as creating, any rights enforceable by any Person not a party to this Agreement. 
 (e) Waiver.
The failure of either party hereto at any time to enforce performance by the other party of any provision of this Agreement shall in no way affect such party’s rights thereafter to enforce the same, nor shall the waiver by either party of any
breach of any provision hereof be deemed to be a waiver by such party of any other breach of the same or any other provision hereof. 
 (f)
Section Headings. The headings of the several sections in this Agreement are inserted solely for the convenience of the parties and are not a part of and are not intended to govern, limit or aid in the construction of any term or provision
hereof. 
 (g) Notices. All notices and other communications hereunder shall be in writing and shall be given by hand delivery to the
other party or by registered or certified mail, return receipt requested, postage prepaid, addressed as follows: 
 If to Executive:
at Executive’s most recent address on the records of the Company. 
 If to the REIT or the Operating Partnership: 

BioMed Realty Trust, Inc. 
 BioMed
Realty, L.P. 
 17190 Bernardo Center Drive 

San Diego, California 92128 

Attention: Chief Executive Officer 
 or to such
other address as either party shall have furnished to the other in writing in accordance herewith. Notice and communications shall be effective when actually received by the addressee. 

(h) Severability. The invalidity or unenforceability of any provision of this Agreement shall not affect the validity or enforceability
of any other provision of this Agreement, which shall remain in full force and effect. 
 (i) Governing Law and Venue. This Agreement
is to be governed by and construed in accordance with the laws of the State of California applicable to contracts made and to be performed wholly within such State, and without regard to the conflicts of laws principles thereof. Except as provided
in Sections 4 and Section 7 herein, any suit brought hereon shall be brought in the state or federal courts sitting in San Diego, California, the parties hereto hereby waiving any claim or defense that such forum is not convenient or proper.
Each party hereby agrees that any such court shall have in personam jurisdiction over it and consents to service of process in any manner authorized by California law. 

  
 9 

 (j) Counterparts. This Agreement may be executed in several counterparts, each of which
shall be deemed to be an original but all of which together shall constitute one and the same instrument. 
 (k) Construction. The
language in all parts of this Agreement shall in all cases be construed simply, according to its fair meaning, and not strictly for or against any of the parties hereto. Without limitation, there shall be no presumption against any party on the
ground that such party was responsible for drafting this Agreement or any part thereof. 
 (l) Code Section 409A. Notwithstanding
anything contained in this Agreement to the contrary, to the maximum extent permitted by applicable law, amounts payable to Executive pursuant to this Agreement shall be made in reliance upon Treas. Reg. Section 1.409A-1(b)(9) (Separation
Pay Plans) or Treas. Reg. Section 1.409A-1(b)(4) (Short-Term Deferrals). This Agreement is intended to be written, administered, interpreted and construed in a manner such that no payment or benefits provided under the Agreement
become subject to (a) the gross income inclusion set forth within Code Section 409A(a)(1)(A) or (b) the interest and additional tax set forth within Code Section 409A(a)(1)(B) (together, referred to herein as the
“Section 409A Penalties”), including, where appropriate, the construction of defined terms to have meanings that would not cause the imposition of Section 409A Penalties. In no event shall the Company be required to provide
a tax gross-up payment to Executive or otherwise reimburse Executive with respect to Section 409A Penalties. For purposes of Section 409A of the Code (including, without limitation, for purposes of Treasury Regulation
Section 1.409A-2(b)(2)(iii)), each payment that Executive may be eligible to receive under this Agreement shall be treated as a separate and distinct payment. Notwithstanding anything to the contrary in this Agreement, in-kind benefits and
reimbursements provided under this Agreement during any tax year of Executive shall not affect in-kind benefits or reimbursements to be provided in any other tax year of Executive and are not subject to liquidation or exchange for another
benefit. Notwithstanding anything to the contrary in this Agreement, reimbursement requests must be timely submitted by Executive and, if timely submitted, reimbursement payments shall be made to Executive as soon as administratively
practicable following such submission, but in no event later than the last day of Executive’s taxable year following the taxable year in which the expense was incurred. In no event shall Executive be entitled to any reimbursement payments
after the last day of Executive’s taxable year following the taxable year in which the expense was incurred. This section shall only apply to in-kind benefits and reimbursements that would result in taxable compensation income to
Executive. 
 (m) Amendment. No provision of this Agreement may be modified, waived or discharged unless such waiver, modification or
discharge is agreed to in writing and signed by Executive and the Chief Executive Officer of the Company. 
 (n) Taxes. All
compensation payable to Executive under this Agreement shall be subject to such deductions as the Company is from time to time required to make pursuant to law, governmental regulation or order. During the Consulting Period, Executive shall be
solely responsible for taxes required to be paid with respect to his performance of Services and the receipt of consideration under this Agreement, including, without limitation, United States federal, state and local income taxes, payroll taxes,
social security, unemployment or disability insurance, or similar items, and Executive will indemnify the Company and hold it harmless from and against all claims, damages, losses and expenses, including reasonable fees and

  
 10 

 
expenses of attorneys, relating to any obligation imposed by law on the Company to pay any withholding taxes, payroll taxes, social security, unemployment or disability insurance, or similar
items in connection with consideration received by Executive for consulting services pursuant to this Agreement, whether such obligations are imposed by the Internal Revenue Service or any other federal, state or local governmental authority. 

(o) RIGHT TO ADVICE OF COUNSEL. EXECUTIVE ACKNOWLEDGES THAT HE HAS THE RIGHT, AND IS ENCOURAGED, TO CONSULT WITH HIS LAWYER AND PERSONAL
TAX ADVISORS; BY HIS SIGNATURE BELOW, EXECUTIVE ACKNOWLEDGES THAT HE HAS CONSULTED, OR HAS ELECTED NOT TO CONSULT, WITH HIS LAWYER AND PERSONAL TAX ADVISORS CONCERNING THIS AGREEMENT AND THAT NEITHER THE COMPANY NOR ITS REPRESENTATIVES OR AGENTS HAS
GIVEN HIM LEGAL OR TAX ADVICE CONCERNING THIS AGREEMENT. 
 (Signature Page Follows) 

  
 11 

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first set forth
above. 
  

	
	
	        /s/ Kent Griffin
	        Kent Griffin

  

					
	BIOMED REALTY TRUST, INC.
		
	By:	 	/s/ Alan D. Gold
		 	Name: Alan D. Gold
		 	Title: Chief Executive Officer

  

					
	BIOMED REALTY, L.P.
		
	By:	 	BioMed Realty Trust, Inc., its general partner
			
		 	By:	 	/s/ Alan D. Gold
		 	Name: Alan D. Gold
		 	Title: Chief Executive Officer

 EXHIBIT A 

RELEASE OF CLAIMS 

For and in consideration of the payments and benefits (the “Separation Benefits”) to be provided to the undersigned pursuant
to Sections 2 and 3(b) and (c) of that certain Employment Transition and Consulting Agreement (the “Transition Agreement”) dated as of February 25, 2015, among the undersigned, BioMed Realty Trust, Inc. (the
“REIT”), and BioMed Realty, L.P. (the “Operating Partnership” and together with the REIT, the “Company”), the receipt and adequacy of which are hereby acknowledged, the undersigned for himself, his
heirs, executors, administrators, assigns and successors, fully and forever releases and discharges the REIT, the Operating Partnership and each of their current, former and future parents, subsidiaries, related entities, employee benefit plans and
their fiduciaries, predecessors, successors, officers, directors, shareholders, agents, employees and assigns (collectively, “Releasees”), with respect to any and all claims, liabilities and causes of action, of every nature, kind
and description, in law, equity or otherwise, which have arisen, occurred or existed at any time prior to the signing of this Release of Claims (this “Release”), including, without limitation, any and all claims, liabilities and
causes of action arising out of or relating to the undersigned’s employment with the Company or the cessation of that employment. 

The undersigned understands and agrees that, with the exception of potential employment-related claims identified below, he is waiving any and
all rights he may have had, now has, or in the future may have, to pursue and/or recover against any of the Releasees any and all remedies available to him under any employment-related causes of action which have arisen, occurred or existed at any
time prior to the signing of this Release, including without limitation, claims of wrongful discharge, breach of contract, breach of the covenant of good faith and fair dealing, fraud, violation of public policy, defamation, discrimination, personal
injury, physical injury, emotional distress, claims under the United States Constitution, the South Carolina State Constitution, Title VII of the Civil Rights Act of 1964, as amended, the Age Discrimination in Employment Act, the Americans With
Disabilities Act, the Federal Rehabilitation Act, the Family and Medical Leave Act, the Equal Pay Act of 1963,and any other federal, state or local laws and regulations relating to employment, conditions of employment (including wage and hour laws),
perquisites of employment (including but not limited to claims relating to stock and/or stock options) and/or employment discrimination, whether such claim be based upon an action filed by the undersigned or by a governmental agency. 

Except as described below, the undersigned agrees and covenants not to file any suit or complaint against the Company in any court with regard
to any claim, demand, liability or obligation arising out of his employment with the Company or separation therefrom. The undersigned further represents that no claims, complaints, charges, or other proceedings are pending in any court,
administrative agency, commission or other forum relating directly or indirectly to his employment with the Company. 
 This Release does
not apply to: (i) any claims or rights that may arise after the date the undersigned signs this Release, (ii) any claims or rights based on the Company’s executory obligations under the Agreement, (iii) any claims or rights the
undersigned may have under the Company’s expense reimbursement policies, (iv) the undersigned’s vested rights under 

 
the Company’s ERISA-covered employee benefit plans as applicable on the date the undersigned signs this Release, (iv) claims for unemployment compensation or any state disability
insurance benefits pursuant to the terms of applicable state law, (v) claims for workers’ compensation insurance benefits under the terms of any worker’s compensation insurance policy or fund of the Company, and (vi) any claims
that the controlling law clearly states may not be released by private agreement. Moreover, nothing in this Release, including but not limited to the release of claims, the promise not to sue, the confidentiality obligations, and the
restriction on use of confidential information, generally prevents the undersigned from filing a charge or complaint with or from participating in an investigation or proceeding conducted by the Equal Employment Opportunity Commission, the National
Labor Relations Board, the California Department of Fair Employment and Housing or any other federal, state or local agency charged with the enforcement of any laws, or from exercising rights under Section 7 of the National Labor Relations Act
to engage in joint activity with other employees, although by signing this Release the undersigned is waiving any right to individual relief based on claims asserted in such a charge or complaint except where such a waiver is prohibited. The
undersigned further waives any right to seek reinstatement to his former position with the Company. 
 The undersigned acknowledges that he
has been advised of and is familiar with the provisions and protections of Section 1542 of the California Civil Code, which reads: 
 A
GENERAL RELEASE DOES NOT EXTEND TO CLAIMS WHICH THE CREDITOR DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE, WHICH, IF KNOWN BY HIM OR HER, MUST HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE
DEBTOR. 
 Being aware of said provision, the undersigned hereby expressly waives any rights he may have thereunder, as well as under any
other statutes or common law principles of similar effect. 
 The undersigned acknowledges that he is knowingly and voluntarily waiving and
releasing any rights he may have under the federal Age Discrimination in Employment Act of 1967, as amended (“ADEA”). He also acknowledges that the consideration given for this waiver and release is in addition to anything of value to
which he already was entitled. The undersigned further acknowledges that he has been advised by this writing, as required by law, that: (a) his waiver and release specified in this paragraph do not apply to any rights or claims that may arise
after the date he signs this Release; (b) he has been advised hereby that he has the right to consult with an attorney of his choosing prior to executing this Release; (c) he has twenty-one (21) days to consider this Release (although
he may choose to voluntarily execute this Release earlier; and, the undersigned represents that if he executes this Release before twenty-one (21) days have elapsed, he does so voluntarily, upon the advice and with the approval of his legal
counsel, and that he voluntarily waives any remaining consideration period); (d) he has seven (7) days following his execution of this Release to revoke the Release (in writing, as provided below); and (e) this Release will not be
effective until the date upon which the revocation period has expired, which will be the eighth (8th) day after this Release is executed by the undersigned, provided that he has not revoked this Release as provided below, and further provided
that the Company has also executed this Release and the Employment Transition and Consulting 

 
Agreement by that date. Any revocation of this Release must be made in writing and received by the Company at 17190 Bernardo Center Drive, San Diego, CA 92128; Attn: General Counsel, no later
than noon on the eighth (8th) calendar day following his execution of this Release. 

The undersigned represents and warrants that there has been no assignment or other transfer of any interest in any claim which he may have
against Releasees, or any of them, and the undersigned agrees to indemnify and hold Releasees, and each of them, harmless from any liability, claims, demands, damages, costs, expenses and attorneys’ fees incurred by Releasees, or any of them,
as the result of any such assignment or transfer or any rights or claims under any such assignment or transfer. It is the intention of the parties that this indemnity does not require payment as a condition precedent to recovery by the
Releasees against the undersigned under this indemnity. 
 The undersigned agrees that if any provision of the release given by him under
this Release is found to be unenforceable, it will not affect the enforceability of the remaining provisions and the courts may enforce all remaining provisions to the extent permitted by law. 

The undersigned further understands and agrees that neither the payment of any sum of money nor the execution of this Release shall constitute
or be construed as an admission of any liability whatsoever by the Releasees, or any of them, who have consistently taken the position that they have no liability whatsoever to the undersigned. 

This Release is to be governed by and construed in accordance with the laws of the State of California applicable to contracts made and to be
performed wholly within such State, and without regard to the conflicts of laws principles thereof. This Release shall be subject to the arbitration provision set forth in Section 7 of the Transition Agreement. 

PLEASE READ CAREFULLY. THIS RELEASE CONTAINS A GENERAL RELEASE OF ALL KNOWN AND UNKNOWN CLAIMS. 

THE UNDERSIGNED ACKNOWLEDGES AND AGREES THAT HE HAS BEEN ADVISED THAT THIS RELEASE IS A BINDING AND LEGAL DOCUMENT. THE UNDERSIGNED FURTHER AGREES THAT HE HAS
HAD AT LEAST TWENTY-ONE (21) DAYS TO REVIEW THE PROVISIONS OF THIS RELEASE AND HAS BEEN ADVISED TO SEEK LEGAL ADVICE REGARDING ALL ITS ASPECTS, AND THAT IN EXECUTING THIS RELEASE THE UNDERSIGNED HAS ACTED VOLUNTARILY AND HAS NOT RELIED UPON ANY
REPRESENTATION MADE BY THE COMPANY OR ANY OF ITS EMPLOYEES OR REPRESENTATIVES REGARDING THIS RELEASE’S SUBJECT MATTER AND/OR EFFECT. THE UNDERSIGNED HAS READ AND FULLY UNDERSTANDS THIS RELEASE AND VOLUNTARILY AGREES TO ITS TERMS. IN THE EVENT
THE UNDERSIGNED HAS NOT SIGNED THIS RELEASE ON OR PRIOR TO THE DATE THAT IS TWENTY-ONE (21) DAYS FOLLOWING THE TERMINATION DATE (AS DEFINED IN THE TRANSITION AGREEMENT), OR THE UNDERSIGNED THEREAFTER REVOKES THIS RELEASE, THE COMPANY SHALL NOT
BE OBLIGATED TO PAY TO THE UNDERSIGNED THE SEPARATION BENEFITS SET FORTH IN SECTIONS 3(B) AND 3(C) OF THE TRANSITION AGREEMENT. 

 IN WITNESS WHEREOF, the undersigned has executed this Release this
         day of             , 2015. 
  

	
	   

	Kent Griffin

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00240-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00240-of-00352.parquet"}]]